Final Insights in Care for Patients With Renal Cell Carcinoma

Opinion
Video

Panelists discuss how next-generation sequencing is transforming precision oncology by enabling comprehensive genomic profiling that identifies actionable mutations, guides targeted therapy selection, and facilitates clinical trial enrollment while acknowledging challenges in data interpretation and implementation across diverse health care settings.

Recent Videos
According to Aditya Bardia, MD, MPH, FASCO, antibody-drug conjugates are slowly replacing chemotherapy as a standard treatment for breast cancer.
Decreasing the low-dose bath of proton therapy to the body may limit the impact of radiation on lymphocytes and affect tumor response.
According to Eyub Akdemir, MD, reducing EDIC may be feasible without compromising target coverage to reduce anticipated lymphopenia rates.
7 experts are featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
4 experts in this video
7 experts are featured in this series.
2 KOLs are featured in this series.
2 experts are featured in this series.
Related Content